|
European Drug Report 2015: Trends and Developments |
alcohol | amphetamines | cannabis | chemistry | co-morbidity | cocaine | consumption rooms | crime | death | demand | drug-law offences | environmental indicators | epidemiology | evaluation | gender | hallucinogens | harm reduction | health effects | heroin | HIV | infectious diseases | injecting | key indicators | law | markets | methodology | new psychoactive substances (NPS) | older people | opioids | overdose | policy | polydrug use | prevalence | prevention | price | prison | problem drug use | public expenditure | purity | recreational drugs | Reitox | research | seizures | social exclusion | social reintegration | spice | statistics | strategies | substitution treatment | supply | synthetic stimulants | trafficking | treatment | trends | young people |
|
2009 Annual report on the state of the drugs problem in Europe |
amphetamines | cannabis | co-morbidity | cocaine | demand | drug-law offences | emcdda | epidemiology | evaluation | hallucinogens | harm reduction | health effects | heroin | HIV | infectious diseases | injecting | law | markets | new psychoactive substances (NPS) | opioids | overdose | policy | polydrug use | prevalence | prevention | price | prison | problem drug use | public expenditure | purity | recreational drugs | research | seizures | social exclusion | social reintegration | spice | strategies | substitution treatment | supply | synthetic stimulants | trafficking | treatment | trends |
|
2010 Annual report on the state of the drugs problem in Europe |
amphetamines | cannabis | co-morbidity | cocaine | crime | death | demand | drug-law offences | emcdda | epidemiology | gender | hallucinogens | health effects | heroin | HIV | infectious diseases | injecting | key indicators | law | markets | new psychoactive substances (NPS) | opioids | overdose | policy | polydrug use | prevalence | prevention | price | prison | problem drug use | public expenditure | purity | recreational drugs | research | seizures | social exclusion | social reintegration | spice | strategies | substitution treatment | supply | synthetic stimulants | trafficking | treatment | trends |
|
Mortality cohort guidelines |
death | epidemiology | health effects | infectious diseases | key indicators | overdose | polydrug use | prevalence | problem drug use | research |
|
Cocaine–related deaths in special and general mortality registries |
cocaine | death | epidemiology | health effects | key indicators | overdose | polydrug use | research |
|
Driving Under the Influence of Drugs, Alcohol and Medicines in Europe — findings from the DRUID project |
alcohol | amphetamines | cannabis | cocaine | death | driving | epidemiology | evaluation | law | methodology | policy | polydrug use | prevalence | prevention | recreational drugs | research | social reintegration | statistics |
|
Drug prevention interventions targeting minority ethnic populations: issues raised by 33 case studies |
policy | prevention | research | social exclusion | young people |
|
Drug-related research in Europe: recent developments and future perspectives |
research |
|
Guidelines for the evaluation of drug prevention: a manual for programme planners and evaluators (second edition) |
evaluation | methodology | prevention | research |
|
Users' voices |
research |